INV-202

· Inversago Pharma Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for INV-202, covering 2025-03-27 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease [Phase 2]